Medicine guide

Respreeza 50 mg/ml à 1 g

As listed in the register: Respreeza 50 mg/ml à 1 g, Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung

50 mg/ml + 1 g ·

  • Prescription only
  • Blood, clotting and anaemia
Made by
CSL Behring AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Erhaltungstherapie für Erwachsene mit schwerem Alpha1-Proteinase-Inhibitor-Mangel und klinisch manifester Lungenerkrankung

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byCSL Behring AG
Active substanceAlpha-1-proteinasi inhibitor humanum
Used inBlood, clotting and anaemia
Strength50 mg/ml + 1 g
ClassificationB02AB02 · Blood, clotting and anaemia
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerRespreeza 50 mg/ml à 1 g, Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung
Packs2 Durchstechflasche(n)
Zulassungsnummer65337
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.